ARHGAP26-IT1: A Drug Target / Disease Biomarker (G100874372)

Target Name: ARHGAP26-IT1

NCBI ID: G100874372

ARHGAP26-IT1

Other Name(s): ARHGAP26 intronic transcript 1

ARHGAP26-IT1: A Drug Target / Disease Biomarker

ARHGAP26-IT1 is a protein that is expressed in various tissues throughout the body. It is a part of the actinin protein family, which is known for their role in cell signaling and cytoskeletal organization. While ARHGAP26-IT1 is not a well-studied protein in its own right, its potential role in disease has been identified through its expression in several diseases, including cancer.

One of the key features of ARHGAP26-IT1 is its ability to interact with other proteins, particularly with the protein known as p16INK4a. This interaction has led some researchers to investigate the role of ARHGAP26-IT1 in the regulation of cell growth and the development of cancer.

Additionally, ARHGAP26-IT1 has been shown to play a role in the regulation of cell death, which is a critical aspect of the immune system's response to cancer. In fact, studies have shown that ARHGAP26-IT1 is involved in the regulation of apoptosis, which is the process by which cells undergo and die.

Another potential function of ARHGAP26-IT1 is its role in the regulation of inflammation. Inflammation is a critical aspect of the immune system's response to infection, and it can lead to a range of diseases, including cancer.

While more research is needed to fully understand the role of ARHGAP26-IT1 in disease, its potential as a drug target is already being investigated. Studies have shown that ARHGAP26-IT1 can be targeted with small molecules, which could lead to new treatments for a range of diseases.

In conclusion, ARHGAP26-IT1 is a protein that has the potential to be a drug target or biomarker for a range of diseases. Further research is needed to fully understand its role in disease and to develop new treatments based on its properties.

Protein Name: ARHGAP26 Intronic Transcript 1

The "ARHGAP26-IT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARHGAP26-IT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets